respiratori
virus
frequent
caus
repeat
common
cold
bronchiti
pneumonia
often
occur
unpredict
epidem
pandem
despit
decim
effect
health
decad
intens
research
treatment
remain
larg
support
commonli
avail
vaccin
influenza
viru
even
need
improv
lung
share
featur
mucos
site
preserv
especi
delic
anatom
structur
necessit
fine
balanc
proand
antiinflammatori
respons
welltim
appropri
place
tightli
regul
cell
b
cell
respons
essenti
protect
infect
limit
symptom
wherea
poorli
regul
inflamm
contribut
tissu
damag
diseas
recent
advanc
understand
adapt
immun
facilit
vaccin
develop
reduc
global
effect
respiratori
virus
lung
gut
open
door
environ
put
special
risk
attack
pathogen
respiratori
infect
second
cardiovascular
diseas
effect
global
health
especi
affect
peopl
extrem
age
respiratori
virus
caus
spectrum
ill
rang
asymptomat
state
lifethreaten
multiorgan
failur
impos
vast
socioeconom
burden
converg
serolog
distinct
virus
one
ecolog
nich
demonstr
uniqu
vulner
respiratori
tract
difficulti
make
progress
divers
pathogen
around
hospit
admiss
children
hospit
adult
communityacquir
pneumonia
associ
respiratori
virus
commonli
respiratori
syncyti
viru
rsv
influenza
viru
respect
addit
rhinovirus
classic
common
cold
viru
human
metapneumoviru
parainfluenza
viru
adenovirus
coronavirus
sometim
caus
seriou
diseas
healthi
peopl
underli
cardiorespiratori
condit
viral
infect
precipit
exacerb
asthma
chronic
bronchiti
toprank
noncommunic
diseas
children
adult
respect
despit
intens
sustain
research
effort
mani
decad
respiratori
virus
continu
decim
respiratori
health
addit
caus
repeat
sporad
season
diseas
constantli
threaten
emerg
epidem
pandem
outbreak
stretch
social
medic
resourc
even
wealthi
nation
clearli
demonstr
pandem
influenza
viru
p
well
zoonos
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
current
licens
gener
avail
vaccin
respiratori
virus
influenza
viru
even
suboptim
pauciti
vaccin
due
part
limit
understand
immun
respons
provid
protect
respiratori
viral
infect
mani
case
even
fundament
correl
protect
yet
accur
defin
appropri
antigen
vaccin
target
remain
unknown
anim
model
gener
imperfect
guid
human
diseas
popul
highest
risk
sever
infect
ie
young
children
elderli
adult
difficult
studi
addit
vaccin
often
less
effect
immatur
senesc
immun
system
immunolog
protect
specif
strain
influenza
viru
persist
mani
year
infect
rhinoviru
also
confer
durabl
serotypespecif
protect
respiratori
virus
evolv
divers
strategi
evad
control
immun
system
includ
vast
antigen
variat
howev
infect
rsv
recur
throughout
life
despit
rel
stabl
antigen
suggest
impair
durabl
protect
immun
respons
mechan
yet
fulli
elucid
understand
mechan
underli
adapt
immun
way
interact
respiratori
virus
therefor
continu
urgent
prioriti
effect
lung
environ
adapt
immun
lung
larg
mucos
gasexchang
surfac
constantli
expos
environ
exchang
oxygen
carbon
dioxid
depend
preserv
delic
anatom
structur
lung
rel
intoler
physic
inflammatori
damag
lung
tissu
therefor
maintain
fine
balanc
toler
nonpathogen
environment
encount
mount
vigor
effect
respons
harm
organ
mechan
prevent
overexuber
respons
environment
antigen
includ
express
centr
respiratori
infect
nation
heart
lung
institut
imperi
colleg
london
london
uk
correspond
address
pjo
popenshaw
imperialacuk
cc
cchiu
imperialacuk
interplay
innat
immun
adapt
immun
improv
knowledg
tissuespecif
factor
local
sampl
becom
increasingli
import
defin
determin
infect
risk
vaccin
develop
special
need
pulmonari
environ
dictat
highli
compartment
sequenti
immun
respons
essenti
minim
loss
function
inflammatori
process
antivir
defens
respiratori
virus
enter
via
respiratori
epithelium
need
circumv
intrins
mechan
protect
includ
mucu
antivir
peptid
prevent
initi
attach
viral
entri
fig
defens
breach
epitheli
cell
central
role
initi
immun
respons
recogn
viral
compon
via
prr
tlr
intracellular
sensor
includ
rigilik
receptor
ligat
lead
signal
cascad
result
upregul
type
iii
interferon
trigger
inflammatori
respons
contribut
differenti
cell
adapt
immun
system
promot
antivir
state
local
alveolar
macrophag
dendrit
cell
dc
patrol
probe
respiratori
lumen
sampl
surround
pick
microbi
compon
contribut
secret
cytokin
chemokin
maintain
step
immun
respons
prr
ligat
cytokin
signal
promot
dc
matur
enabl
induct
adapt
immun
respons
via
antigen
present
eat
signal
molecul
mucin
surfact
protein
along
reduc
express
patternrecognit
receptor
prr
tolllik
receptor
tlr
event
infect
mechan
restor
epitheli
integr
lung
function
also
rapidli
engag
exampl
innat
lymphoid
cell
involv
gener
proinflammatori
cytokin
also
airway
remodel
tissu
repair
follow
infect
influenza
viru
although
long
believ
essenti
steril
clear
lower
respiratori
tract
colon
varieti
rel
fastidi
organ
gener
innocu
may
necessari
mainten
mucos
defenc
well
known
gut
intestin
microbiota
influenc
local
system
immun
becom
increasingli
clear
also
case
lung
although
inflamm
respons
commens
respiratori
flora
tightli
restrain
bacteri
product
maintain
basal
activ
state
lung
epitheli
cell
stimul
via
prr
furthermor
type
abund
bacteri
fungal
speci
may
well
differenti
influenc
immun
respons
trigger
pathogen
sinc
cell
immun
system
traffic
equal
peripher
blood
lung
local
factor
confer
addit
level
complex
attempt
understand
mucos
immun
respons
especi
true
human
direct
sampl
respiratori
tissu
difficult
imposs
extrapol
studi
peripher
blood
may
mislead
understand
figur
role
adapt
cell
b
cell
respiratori
viral
infect
acut
respiratori
viral
infect
humor
cellmedi
immun
act
differ
point
time
limit
diseas
mucos
iga
gener
previou
encount
viru
prevent
limit
infect
igg
lung
limit
sever
diseas
cell
benefici
term
elimin
virusinfect
cell
coordin
regul
immun
respons
fh
cell
promot
highaffin
durabl
antibodi
failur
control
viral
dissemin
lead
sever
diseas
reg
cell
restrain
effector
respons
variou
mechan
includ
suppress
cytokin
tgfb
possibl
activ
kill
via
perforin
granzym
b
gzmb
overexuber
poorli
regul
immun
respons
also
lead
damag
immunopatholog
kim
caesarnatur
publish
group
may
also
confer
crossreact
protect
differ
strain
influenza
viru
rapid
mutat
viral
ha
neuraminidas
na
protein
allow
viru
evad
immun
system
although
titer
circul
antibodi
correl
protect
infect
may
reflect
local
protect
iga
igg
also
thought
direct
role
defens
lower
respiratori
tract
abund
nasal
mucos
fluid
rsv
diseas
illustr
clinic
efficaci
human
mous
monoclon
antibodi
palivizumab
administr
reduc
hospit
prematur
infant
reliabl
prevent
nasal
infect
virusspecif
b
cell
respons
gener
mainli
lymphoid
tissu
either
region
drain
lymph
node
mucosaassoci
lymphoid
tissu
nose
bronchu
tertiari
lymphoid
aggreg
induc
bronchusassoci
lymphoid
tissu
form
respiratori
infect
mice
aggreg
preferenti
promot
iga
b
cell
respons
persist
respons
difficult
demonstr
human
airway
earli
antibodi
product
occur
local
influenc
b
celltroph
factor
baff
april
produc
dc
b
cell
gener
way
shortliv
undergo
affin
matur
classic
differenti
pathway
b
cell
cell
depend
result
product
highaffin
antibodysecret
cell
memori
b
cell
matur
dc
migrat
secondari
tertiari
lymphoid
tissu
carri
virusderiv
antigen
present
b
cell
migrat
nodal
tissu
fig
recognit
antigen
begin
program
differenti
caus
migrat
edg
lymphoid
follicl
prolifer
contact
helper
cell
recogn
cognat
antigen
present
b
cell
via
major
histocompat
complex
class
ii
lead
immunoglobulin
isotyp
class
switch
igm
igg
iga
prolifer
occur
interact
costimulatori
receptor
costimul
furthermor
inflammatori
mediat
recruit
innat
cell
includ
neutrophil
critic
natur
killer
cell
abil
kill
virusinfect
cell
via
perforingranzymedepend
mechan
type
ii
transmembran
protein
cytokin
fasl
via
receptor
fa
well
product
interferong
ifng
variou
immunostimulatori
effect
polar
incom
cell
antivir
cytolyt
helper
type
h
respons
respons
airway
epitheli
myeloid
cell
initi
stage
viral
infect
therefor
critic
import
subsequ
develop
adapt
immun
respons
recruit
primari
secondari
cell
adapt
immun
system
site
infect
also
provid
costimulatori
signal
need
induc
program
prolifer
differenti
matur
b
cell
cell
enabl
earli
control
clearanc
infect
follow
contract
establish
durabl
memori
protect
futur
infect
best
defin
correl
protect
almost
infecti
diseas
antibodi
although
correl
proof
causat
highli
plausibl
antibodi
appropri
site
direct
role
protect
infect
system
dissemin
antibodi
neutral
infect
directli
bind
viral
surfac
protein
essenti
entri
viru
host
cell
fig
properti
underli
commonli
use
serolog
measur
immun
influenza
viru
hemagglutin
inhibit
detect
hemagglutinin
ha
specif
antibodi
abil
block
ha
receptorbind
site
prevent
clump
togeth
red
blood
cell
exposur
influenza
viru
vitro
function
neutral
antibodi
respiratori
virus
includ
influenza
viru
rsv
measur
plaquereduct
assay
although
method
requir
standard
addit
neutral
virus
antibodi
also
act
ligat
fc
receptor
enabl
trigger
complement
cascad
antibodydepend
cellmedi
cytotox
fig
import
mechan
less
well
defin
import
viru
neutral
mechan
may
import
adjunct
viral
clearanc
also
quantifi
differ
aspect
antibodymedi
effector
function
assay
measur
therefor
import
consider
determin
correl
protect
antibodymedi
correl
protect
defin
serum
main
immunoglobulin
isotyp
igg
howev
peripher
blood
probabl
site
antibodi
import
prevent
infect
respiratori
virus
instead
exclus
immun
system
occur
mainli
respiratori
mucosa
virusspecif
antibodi
act
concert
physic
barrier
antivir
substanc
secret
respiratori
epithelium
fig
mucos
antibodi
particularli
upper
respiratori
tract
mainli
form
local
produc
dimer
secretori
iga
igadefici
mice
highli
suscept
influenza
viru
rsv
short
halflif
rsvspecif
antibodi
remain
unknown
probabl
explain
lifelong
suscept
recurr
infect
viru
fh
cell
fh
cell
first
describ
cell
subset
tonsil
special
help
gener
mainten
highaffin
b
cell
antibodi
respons
fh
cell
express
characterist
set
marker
includ
chemokin
receptor
allow
home
gc
chiefli
resid
ico
sap
lineagespecifi
transcript
factor
local
gc
allow
close
contact
prolifer
b
cell
follicular
dc
fh
cell
deliv
signal
promot
preferenti
select
differenti
allow
b
cell
outcompet
lowaffin
suboptim
clone
well
particip
direct
celltocel
signal
fh
cell
produc
promot
isotyp
switch
iga
enhanc
express
b
cell
thu
augment
memori
gener
fh
cell
therefor
essenti
durabl
protect
antibodi
respons
potenti
key
effici
gener
vaccineinduc
antivir
immun
respiratori
infect
infect
rsv
impair
antigen
present
cell
inhibit
type
interferon
signal
role
modul
fh
cell
respons
although
yet
data
fh
cell
human
infect
rsv
possibl
defect
fh
cell
help
impair
signal
might
contribut
poor
longev
rsvspecif
antibodi
respons
differenti
pathway
fh
cell
fulli
understood
common
gc
b
cell
fh
cell
express
express
factor
cell
type
requir
gc
reaction
occur
express
fh
cell
suppress
express
lineagespecif
transcript
factor
remov
effect
microrna
suppress
ico
thu
promot
fh
cell
phenotyp
howev
key
trigger
differenti
fh
cell
phenotyp
remain
controversi
cell
exhibit
high
degre
plastic
convers
fh
cell
subset
helper
cell
includ
h
h
h
cell
describ
variou
system
depend
environment
context
cytokin
milieu
infect
type
vitro
fh
cell
induc
express
type
cytokin
appropri
polar
signal
anim
model
also
shown
express
vivo
howev
sever
studi
suggest
lineag
decis
h
cell
fh
cell
occur
earli
activ
naiv
cell
fh
cell
phenotyp
maintain
stabli
memori
phase
may
due
persist
antigen
avail
longer
engag
cell
antigen
receptor
promot
fh
cell
fate
h
lineag
fate
convers
mous
model
infect
influenza
viru
shown
polar
cell
h
phenotyp
away
fh
cell
phenotyp
defect
gc
b
cell
respons
system
administ
human
studi
limit
access
lymphoid
tissu
driven
search
fh
like
cell
peripher
blood
subject
receiv
inactiv
influenza
vaccin
cell
cultur
autolog
b
cell
vitro
help
differenti
plasmablast
product
influenza
virusspecif
antibodi
fh
like
cell
also
express
ico
seem
repres
earli
popul
peripher
blood
correl
subsequ
respons
vaccin
exact
relationship
fh
cell
gc
remain
unclear
express
function
vivo
unknown
therefor
type
qualiti
interact
fh
cell
b
cell
probabl
import
role
support
plasma
cell
ligand
cytokin
signal
via
interleukin
ifng
particularli
case
iga
transform
growth
factorb
tgfb
shortliv
plasmablast
form
stage
b
cell
progress
particip
germin
center
gc
reaction
somat
hypermut
affin
matur
occur
promot
special
follicular
helper
cell
fh
cell
express
costimulatori
receptor
ico
costimulatori
molecul
marker
driven
transcript
repressor
ref
follow
multipl
round
select
highaffin
antibodysecret
cell
gener
nonantibodysecret
memori
b
cell
former
respons
abrupt
increas
antibodi
titer
occur
rel
earli
infect
popul
contract
follow
antigen
clearanc
leav
small
number
longliv
plasma
cell
cell
migrat
surviv
nich
includ
bone
marrow
respiratori
mucosa
respons
mainten
longterm
antibodi
titer
tlr
signal
crucial
process
b
cell
potenti
directli
promot
immunoglobulin
product
adjuv
enhanc
antibodi
product
via
similar
b
cellintrins
mechan
imprint
b
cell
lead
upregul
homolog
promot
longterm
surviv
plasma
cell
number
persist
plasma
cell
thu
determin
sequenc
fate
decis
depend
integr
varieti
signal
immedi
choic
prolifer
death
perifollicular
b
cell
first
day
antigen
encount
differenti
shortliv
extrafollicular
plasma
cell
particip
gc
reaction
posit
select
affin
b
cell
receptor
viral
antigen
rather
self
antigen
gener
b
cell
clone
increasingli
higher
affin
longterm
surviv
versu
death
result
antibodysecret
cell
memori
b
cell
pois
gener
greater
rapid
secondari
respons
reencount
antigen
secondari
activ
memori
b
cell
lead
earli
prolifer
product
antibodi
wherea
subset
cell
go
particip
gc
reaction
affin
matur
replenish
memori
pool
fate
memori
b
cell
probabl
determin
earli
stage
marker
includ
defin
subset
undergo
earli
differenti
plasmablast
reenter
gc
b
cell
memori
particularli
import
respons
respiratori
virus
peopl
commonli
expos
multipl
time
throughout
live
classic
recurr
encount
viral
antigen
lead
boost
antibodi
titer
ultim
lead
complet
protect
howev
respiratori
virus
evolv
divers
way
evad
host
immun
strategi
includ
aforement
mutat
gene
encod
surfac
antigen
determin
ha
na
influenza
viru
reassort
gene
segment
lead
wholesal
replac
variant
zoonot
strain
human
popul
preexist
immun
similarli
rhinovirus
diversifi
distinct
serotyp
crossprotect
weak
nonexist
contrast
rsv
rel
well
conserv
attach
g
glycoprotein
display
substanti
antigen
divers
despit
fact
major
rsv
surfac
antigen
f
protein
highli
conserv
across
rsv
strain
f
proteinspecif
antibodi
easili
detect
adult
recurr
infect
rsv
occur
throughout
life
even
absenc
immunolog
defect
might
explain
express
variou
protein
immunomodulatori
potenti
affect
immunolog
memori
includ
nonstructur
protein
interfer
type
iii
interferon
fractalkinelik
motif
g
protein
reason
underli
remark
rapid
decreas
protect
immun
infect
follow
clearanc
viru
effector
cell
popul
contract
leav
longliv
memori
cell
like
memori
b
cell
readi
combat
secondari
infect
divers
signal
intens
antigen
avail
costimulatori
signal
cytokin
milieu
lead
heterogen
popul
memori
cell
categor
function
subset
anim
model
human
accord
express
surfac
marker
recent
two
major
subset
memori
cell
recogn
central
memori
cell
express
lymph
nodehom
receptor
chemokin
receptor
allow
circul
blood
lymphoid
tissu
effector
memori
cell
express
receptor
display
heighten
effector
abil
togeth
popul
abil
selfrenew
reencount
cognat
antigen
prolifer
rapidli
upregul
cytotox
effector
molecul
although
memori
cell
circul
peripher
tissu
adopt
transfer
parabiosi
studi
indic
mani
cell
nonlymphoid
organ
regularli
appear
blood
lymphoid
tissu
initi
describ
gut
addit
memori
cell
subset
resid
memori
cell
rm
cell
also
found
site
unlik
central
memori
effector
memori
cell
rm
cell
seem
restrict
tissu
includ
gut
genit
mucosa
skin
lung
fig
site
major
portal
pathogen
entri
special
memori
cell
might
provid
earli
innatelik
cellmedi
protect
certainli
rm
cell
capabl
rapid
upregul
effector
molecul
innatelik
sens
function
contribut
protect
heterosubtyp
immun
infect
mice
influenza
viru
rm
cell
share
similar
effector
memori
cell
suggest
might
deriv
common
precursor
howev
rm
cell
variou
site
share
transcript
profil
distinguish
memori
cell
subset
suggest
cell
program
local
anatom
environment
cue
commonli
express
ctype
lectin
normal
marker
recent
activ
integrin
e
b
identifi
antibodi
e
addit
collagenbind
integrin
import
retain
rm
cell
lung
development
pathway
lung
rm
cell
remain
elucid
seem
requir
sequenc
differenti
step
drain
lymph
node
antigen
present
dc
predispos
cell
effector
differenti
abil
enter
inflam
tissu
via
express
receptor
downregul
contrast
hi
dc
preferenti
prime
central
memori
celllik
cell
addit
effector
cell
destin
lung
express
combin
chemokin
receptor
includ
ref
genit
mucosa
mice
macrophag
make
chemokin
attract
retain
rm
cell
follow
migrat
rm
cell
site
infect
strength
signal
via
cell
antigen
receptor
avail
addit
signal
via
costimulatori
receptor
cytokin
drive
differenti
toward
termin
differenti
shortliv
effector
state
later
cours
infect
toward
memori
precursor
cell
environment
cue
probabl
govern
commit
rm
cell
phenotyp
exampl
express
herp
simplex
virusspecif
cell
present
infect
skin
certain
length
time
import
among
local
signal
tgfb
produc
regulatori
cell
reg
cell
lesser
extent
activ
cell
respiratori
epithelium
upon
recognit
antigen
present
dc
cell
secret
latent
form
dimer
latencyassoci
protein
lap
interact
integrin
v
b
dc
longev
antibodi
persist
although
studi
investig
human
limit
potenti
translat
effect
understand
role
fh
cell
clear
addit
novel
intracellular
pathway
increasingli
recogn
regul
differenti
function
fh
cell
therefor
affect
b
cell
fate
exampl
microrna
cluster
requir
differenti
fh
cell
migrat
b
cell
follicl
moreov
inactiv
impair
differenti
fh
cell
format
gc
secret
highaffin
antibodi
cellspecif
transgen
express
enhanc
gener
fh
cell
lead
fatal
autoimmun
area
innov
research
show
particular
promis
improv
vaccin
design
tissueresid
memori
cell
well
contribut
protect
help
b
cell
respons
cellmedi
immun
may
directli
contribut
viral
clearanc
cell
abund
lung
mucosa
estim
cell
uninflam
human
lung
compar
total
number
blood
virusspecif
cell
increas
frequenc
number
infect
mice
cell
defici
show
delay
viru
elimin
impair
gener
antibodi
influenza
viru
rsv
children
cell
immunodefici
also
unabl
clear
respiratori
virus
sinc
cell
recogn
mainli
rel
conserv
intern
viral
protein
potenti
mediat
crossprotect
secondari
infect
serolog
distinct
viru
strain
demonstr
experiment
human
model
infect
influenza
viru
preexist
cell
peripher
blood
correl
diminish
suscept
natur
experiment
infect
influenza
viru
circumst
specif
antibodi
absent
preexist
crossreact
cell
also
shown
reduc
sever
symptom
natur
infect
influenza
viru
howev
although
live
attenu
vaccin
influenza
viru
induc
cell
direct
conserv
epitop
littl
clinic
evid
confer
substanti
heterosubtyp
protect
less
known
role
cell
protect
respiratori
viral
diseas
probabl
mani
common
clear
circul
cell
protect
viral
diseas
correl
protect
possibl
reflect
local
pulmonari
cell
actual
mediat
viral
clearanc
parallel
initi
b
cell
respons
cell
prime
antigen
carri
drain
lymph
node
activ
dc
follow
engag
cell
antigen
receptor
appropri
costimulatori
signal
cell
undergo
program
differenti
rapidli
commit
format
enlarg
effector
pool
cell
acquir
cytolyt
activ
upregul
chemokin
receptor
allow
migrat
inflam
site
detect
virusinfect
cell
bind
viral
peptid
present
context
major
histocompat
complex
class
cell
recogn
viral
peptid
present
major
histocompat
complex
class
iibear
cell
differenti
depend
environment
context
strength
interact
varieti
helper
cell
subset
make
specif
cytokin
combin
although
certain
circumst
h
cell
h
cell
induc
potenti
role
immunopatholog
protect
respons
respiratori
virus
typic
domin
ifng
therefor
bias
toward
h
respons
promot
cytolyt
activ
viral
clearanc
notabl
rapid
prolifer
cell
occur
local
node
rather
lung
possibl
remov
intens
activ
immun
system
delic
respiratori
structur
formalininactiv
vaccin
rsv
firsv
assess
trial
children
fail
induc
protect
immun
also
caus
vaccineenhanc
diseas
subsequ
natur
exposur
rsv
sever
mechan
may
contribut
effect
includ
gener
carbonyl
side
chain
viral
antigen
lowaffin
poorli
neutral
antibodi
caus
deposit
inflammationpromot
immunocomplex
aberr
skew
cell
toward
h
respons
lack
induct
reg
cell
recruit
lung
inappropri
gener
helper
cell
subset
might
also
factor
neonat
whose
adapt
immun
tend
toward
type
respons
bronchiolit
children
suggest
h
cell
cytokin
role
immunopatholog
well
variou
intrins
mechan
lung
restrain
inflamm
cell
regul
adapt
immun
respons
balanc
tissu
damag
clearanc
viru
achiev
follow
migrat
inflam
site
effector
cell
upregul
lead
overal
dampen
adapt
respons
neg
feedback
mechan
cell
also
upregul
inhibitori
receptor
signal
receptor
suppress
effector
function
antigen
clear
rapid
contract
b
cell
cell
popul
occur
apoptosi
addit
special
reg
cell
well
recogn
import
modul
multipl
immun
mechan
prevent
autoimmun
well
immunopatholog
respons
viral
infect
interestingli
also
found
promot
fh
cell
differenti
limit
avail
suppress
fh
cell
fig
reg
cell
character
express
transcript
factor
make
cell
reg
cell
specif
microbi
proteas
influenza
viru
neuraminidas
trigger
releas
activ
form
act
naiv
cell
inhibit
differenti
highaffin
h
h
cell
retino
acid
promot
differenti
induc
reg
cell
presenc
tgfb
drive
differenti
regulatori
h
cell
fig
lung
influenza
virusinfect
mice
contain
abund
rm
cell
respons
heterosubtyp
immun
present
month
mechan
underli
subsequ
decreas
frequenc
rm
cell
unclear
might
possibl
includ
insuffici
constitut
express
tgfb
respiratori
tract
also
intrigu
lung
rm
cell
select
express
interferoninduc
transmembran
protein
defect
case
sever
infect
influenza
viru
lung
rm
cell
lack
suscept
infect
influenza
viru
undergo
select
deplet
subsequ
infect
suggest
express
promot
surviv
rm
cell
although
respiratori
virus
direct
cytopath
effect
lung
tissu
diseas
also
attribut
overexuber
immun
respons
caus
tissu
damag
destroy
virusinfect
cell
describ
immunolog
cytokin
storm
abund
cell
inflammatori
mediat
contribut
diseas
viral
bronchiol
often
due
rsv
infiltr
inflammatori
cell
edema
tissu
necrosi
thought
lead
respiratori
failur
due
airflow
obstruct
alveolar
collaps
atelectasi
follow
infect
mice
rsv
deplet
either
cell
popul
cell
popul
typic
lead
reduct
diseas
sever
also
impair
clearanc
viru
fig
howev
sever
respiratori
viral
infect
seem
like
runaway
activ
adapt
immun
either
dysregul
immun
system
driven
reduc
viral
control
host
immun
major
compon
exampl
highli
pathogen
strain
influenza
viru
includ
recent
emerg
avian
strain
cross
human
popul
encod
protein
interfer
type
interferon
activ
also
associ
increas
releas
inflammatori
cytokin
rsv
also
encod
suppress
type
interferon
evid
rsv
g
protein
contain
region
structur
similar
chemokin
fractalkin
thu
promot
inappropri
inflammatori
respons
although
long
assum
immunolog
factor
central
role
pathogenesi
rsv
influenza
viru
diseas
assumpt
challeng
find
sever
diseas
character
inadequ
rather
excess
adapt
immun
respons
robust
viral
replic
viral
host
factor
interact
predispos
certain
peopl
aberr
respons
normal
regulatori
mechan
fail
discuss
elsewher
figur
mainten
tissu
local
function
rm
cell
mucosa
mucos
lymphocyt
cluster
mlc
form
rm
cell
viral
infect
act
sensori
cell
well
earli
effector
cell
reencount
pathogen
maintain
upregul
allow
rm
cell
resist
apoptosi
viral
infect
basal
level
ifng
product
rm
cell
activ
tissu
macrophag
releas
keep
rm
cell
situ
prevent
migrat
cell
mucos
lymphocyt
cluster
lumen
airway
polyfunct
product
rm
cell
activ
granzym
b
product
natur
killer
nk
cell
lymphocyt
wherea
tumornecrosi
factor
tnf
activ
dc
carri
antigen
region
node
therebi
initi
activ
cell
cm
cell
central
memori
cell
em
cell
effector
memori
cell
kim
caesarnatur
publish
group
respons
highrisk
popul
young
children
elderli
adult
howev
techniqu
allow
direct
sampl
respiratori
tract
constantli
improv
provid
hope
ration
develop
vaccin
therapeut
continu
acceler
differenti
thymu
act
mainli
maintain
toler
self
antigen
contrast
induc
reg
cell
gener
follow
exposur
cognat
antigen
context
cytokin
tgfb
follow
infect
rsv
activ
reg
cell
accumul
mous
lung
reduc
diseas
sever
suppress
antigenspecif
effector
cell
also
role
control
vaccineenhanc
diseas
follow
vaccin
firsv
transfer
convent
cell
augment
diseas
wherea
recruit
reg
cell
lung
amelior
thu
unregul
promot
proinflammatori
adapt
immun
respons
vaccin
may
wholli
desir
role
immunomodulatori
mechan
respiratori
viral
infect
need
consid
detail
vaccin
specif
therapi
respiratori
viral
pathogen
essenti
limit
influenza
viru
although
vaccin
adenoviru
avail
militari
use
usa
although
inactiv
vaccin
iiv
live
attenu
vaccin
laiv
influenza
viru
well
establish
vaccin
program
remain
suboptim
term
immunogen
mani
popul
requir
regular
revaccin
overcom
variat
influenza
viru
strain
iiv
laiv
must
reformul
year
unexpectedli
poor
match
vaccin
circul
strain
influenza
viru
reduc
efficaci
less
even
healthi
matur
immun
system
laiv
deliv
intranas
shown
induc
mucos
immun
respons
akin
natur
infect
demonstr
effect
laiv
heterosubtyp
immun
furthermor
laiv
gener
ineffect
older
adult
preexist
immun
block
local
infect
vaccineinduc
immun
respons
rsv
vaccin
develop
slow
concern
vaccineenhanc
immunopatholog
inadequ
defin
correl
protect
well
specif
difficulti
induc
appropri
immun
respons
infant
candid
vaccin
respiratori
virus
includ
parainfluenza
viru
held
back
scientif
reason
econom
reason
therefor
substanti
clinic
need
remain
develop
vaccin
antivir
agent
immunomodulatori
therapeut
base
increas
understand
immun
patholog
respons
respiratori
tract
advanc
defin
critic
protect
epitop
revit
area
develop
vaccin
respiratori
virus
find
crossreact
ha
stembind
antibodi
follow
infect
influenza
viru
vaccin
suggest
heterosubtyp
immun
might
achiev
via
antibodymedi
mechan
well
via
cell
elucid
structur
conform
rsv
f
protein
reveal
novel
epitop
might
allow
better
target
antibodi
respons
infecti
virion
understand
linear
conform
epitop
respiratori
virus
necessari
cellular
immun
humor
immun
brought
vaccineinduc
protect
immun
respons
tightli
regul
respiratori
tract
distinct
adapt
immun
innat
immun
increasingli
blur
local
innat
signal
profoundli
influenc
pattern
intens
acquir
respons
also
cell
b
cell
assum
function
classic
associ
innat
immun
mucos
immun
respons
highli
local
direct
studi
lung
cell
tissu
fluid
rather
find
correl
peripher
blood
therefor
essenti
particularli
problemat
human
much
remain
learn
immun
